Publication:
Paragonimus heterotremus and other Paragonimus spp. in Thailand: Pathogenesis, clinical features and treatment

dc.contributor.authorS. Vanijanontaen_US
dc.contributor.authorD. Bunnagen_US
dc.contributor.authorT. Harinasutaen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-12T07:44:41Z
dc.date.available2018-10-12T07:44:41Z
dc.date.issued1984-01-01en_US
dc.description.abstractSix species of Paragonimus have been reported in Thailand: P. siamensis in cat, bandicoot and rat; P. bangkokensis in mongoose; P. harinasutai in cat and dog (experiment); P. macrochis in bandicoot and rat; P. westermani in tiger and P. heterotremus in cat, dog and man. It is interesting to note that in 1965 two immature P. heterotremus worms were recovered for the first time in man, namely in subcutaneous swellings in a boy; in 1981, 9 mature P. heterotremus worms were expectorated after praziquantel treatment. P. heterotremus has been postulated to be the main cause of human paragonimiasis in Thailand. The clinical manifestation of paragonimiasis heterotremus is similar to paragonimiasis westermani. In the 1960's and 1970's bithionol was used to treat paragonimiasis, the cure rate was only 50-60%, and side effects including urticaria, rash, abdominal pain, nausea, vomiting, diarrhoea and dizziness were common. In the past 4 years, niclofolan and praziquantel ((2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinol in-4-one, EMBAY 8440, Biltricide®) have been used. A single dose of 2 mg/kg body weight of niclofolan yielded a 100% cure rate. Praziquantel at dosages of 3 x 25 mg/kg body weight daily for 1 day and 2 days gave 80% and 100% cure rates, respectively. The eggs disappeared in 2-3 weeks with improvement of symptoms and signs, but radiologically lesions took a few months or more to clear, depending on size and severity. Side effects in the niclofolan group were higher; in the praziquantel group side effects were minimal and no toxic effects were detected.en_US
dc.identifier.citationArzneimittel-Forschung/Drug Research. Vol.34, No.9 B (1984), 1186-1188en_US
dc.identifier.issn00044172en_US
dc.identifier.other2-s2.0-0021179272en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/30712
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0021179272&origin=inwarden_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleParagonimus heterotremus and other Paragonimus spp. in Thailand: Pathogenesis, clinical features and treatmenten_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0021179272&origin=inwarden_US

Files

Collections